Phase 2b open label randomized controlled trial to evaluate the efficacy, safety and tolerability of N-acetylcysteine in reducing adverse drug reactions among adults treated for multidrug-resistant tuberculosis in Tanzania. (Trial Acronym NAC Trial).
Research Square (Research Square)